Intestinal Obstruction Completed Phase 2 Trials for Lanreotide (DB06791)
Also known as: Obstruction Bowel / Bowel Obstruction / Other intestinal obstruction / Unspecified intestinal obstruction / Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction / Obstruction intestinal / Intestinal obstruction (disorder) / Intestinal obstruction NOS
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031423 (Intestinal Obstruction) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02275338 | Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction | Supportive Care |